Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 1. Pharmacodynamic and pharmacokinetic properties
- 1 May 1979
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 97 (5) , 663-670
- https://doi.org/10.1016/0002-8703(79)90195-9
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 5. Pindolol (LB-46) therapy for supraventricular arrhythmia: a viable alternative to propranolol in patients with bronchospasmAmerican Heart Journal, 1979
- HypertensionDrugs, 1976
- Effects of oxprenolol on the airways of normal and bronchitic subjectsEuropean Journal of Clinical Pharmacology, 1976
- Clinical Pharmacokinetics of β-Adrenoreceptor Blocking DrugsClinical Pharmacokinetics, 1976
- Noninvasive assessment of clinical response to oral propranolol therapyThe American Journal of Cardiology, 1975
- Selectivity in Beta-Adrenergic ResponsesCirculation, 1974
- Non-invasive assessment of clinical response to oral propranololThe American Journal of Cardiology, 1974
- Pharmacokinetic Properties of the ??-Adrenergic Receptor Blocking DrugsDrugs, 1974
- ??-Adrenergic Receptor Blocking Drugs in Cardiac Arrhythmias1Drugs, 1974
- Comparison of the beta adrenergic blocking properties and negative inotropic effects of oxprenolol and propranolol in patientsThe American Journal of Cardiology, 1972